Sirio Pharma Co

Sirio Pharma Co FCF Yield

The Free Cash Flow Yield of Sirio Pharma Co (300791.SZ) as of Nov 5, 2026 is 1.93 %. In the previous year, Free Cash Flow Yield was 2.32 % — a change of -16.74% (lower).

FCF Yield

1.93 %

YoY

-16.74%

Last updated:

Free Cash Flow Yield of Sirio Pharma Co is 2025 1.93 % . Free Cash Flow Yield of Sirio Pharma Co was 2024 2.32 % . It decreases by -16.74% lower compared to the previous year.

The Sirio Pharma Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-0.84 CNY
Jan 1, 2019
0.97 CNY
Jan 1, 2020
1.45 CNY
Jan 1, 2021
-2.75 CNY
Jan 1, 2022
2.27 CNY
Jan 1, 2023
-0.98 CNY
Jan 1, 2024
2.32 CNY
Jan 1, 2025
1.93 CNY
The Sirio Pharma Co FCF Yield history
YEARFCF YieldYoY
1.93 %-16.74%
2.32 %-335.96%
-0.98 %-143.41%
2.27 %-182.47%
-2.75 %-290.09%
1.45 %+49.03%
0.97 %-215.82%
-0.84 %-49.43%
-1.66 %-35.37%
-2.56 %+218.27%
-0.81 %-343.00%
0.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sirio Pharma Co Stock analysis

What does Sirio Pharma Co do? Sirio Pharma Co Ltd is a company based in Shantou, China, operating within the Consumer Staples sector and the Consumer products industry. The company went public on the Shenzhen Stock Exchange on September 25, 2019, with the ticker symbol 300791.SZ and ISIN CNE100003NB0. It employs 2,193 full-time staff and is engaged in the manufacturing of dietary supplement products. Sirio Pharma's product range includes soft capsules, tablets, powders, soft candy, hard capsules, and oral liquids. The company markets its products under the brand name WEWOW nutritional health food, distributing them both domestically within China and internationally. The company's official website is https://www.siriopharma.com/. Sirio Pharma focuses on the production and distribution of dietary supplements, targeting health-conscious consumers through its branded offerings. The firm's operations are centered in Shantou, Guangdong, and it serves markets in China and abroad. The company's primary business activities involve the development, manufacturing, and sale of dietary supplements, with a presence in both local and international markets. Sirio Pharma does not disclose specific details about its revenue, market share, or additional product lines beyond those mentioned. Sirio Pharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sirio Pharma Co stock

Free Cash Flow Yield of Sirio Pharma Co is 1.93 % in 2025.

Free Cash Flow Yield of Sirio Pharma Co changed from 2.32 % to 1.93 %, representing a -16.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Sirio Pharma Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Sirio Pharma Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Sirio Pharma Co

All Key Metrics — Sirio Pharma Co